Amgen

RIABNI - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5123

HCPCS Code Descriptor:

Injection, rituximab-arrx, biosimilar, (riabni), 10 mg

Medicare Payment Limit:

The RIABNI Medicare Payment Limit is $41.418

Average Sale Price:

RIABNI ASP cost available once logged in. Riabni is a biosimilar drug making the ASP calculation more complex. Riabni's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The RIABNI Medicare Co-insurance percentage is 20%. RIABNI's Medicare Co-insurance amount is $8.28 per HCPCS unit.

APC Code:

The Riabni APC Code is: 9411

APC Payment Limit:

The APC Payment Limit for RIABNI is available. Login to view.

Riabni Cost Information:

Riabni is a biosimilar for the drug Rituxan with the active ingredient rituximab. Riabni’s Q Code: Q5123 became effective on July 1st, 2021, and the WAC/AWP list prices have remained steady since. Like other biosimilars, Riabni has faced competition from the other rituximab drugs and its average sales price has dropped steadily since its effective date.

ACCESS PRICING AND MORE BY REGISTERING

Riabni’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2021
Riabni’s average wholesale price (AWP) information was last updated on:
January 1, 2021